Sunesis is Biotechnology in United States that focus on Sunesis Pharmaceuticals Inc business. Founded in 1998. They cover business area such as Sunesis Pharmaceuticals Inc, commercialization, its pipeline, oncology therapeutic, solid and hematologic cancer, Vosaroxin, acute myeloid leukemia, AML, research, development, corporate collaborator, licensing, pharmaceutical compound, technology, clinical trial, capital, revenue, license and collaboration agreement.
1998
( 26 years old in 2024 )
Sunesis Pharmaceuticals Inc
-
395 Oyster Point Boulevard
Suite 400
South San Francisco, CA 94080
United States
Private
Sunesis Pharmaceuticals Inccommercializationits pipelineoncology therapeuticsolid and hematologic cancerVosaroxinacute myeloid leukemiaAMLresearchdevelopmentcorporate collaboratorlicensingpharmaceutical compoundtechnologyclinical trialcapitalrevenuelicense and collaboration agreement
* We use standard office opening hours in near Sunesis's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Sunesis is Biotechnology business from United States that founded in 1998 (26 years old in 2024), Sunesis business is focusing on Sunesis Pharmaceuticals Inc.
Sunesis headquarter office and corporate office address is located in 395 Oyster Point Boulevard Suite 400 South San Francisco, CA 94080 United States.
Sunesis was founded in United States.
In 2024, Sunesis is currently focus on Sunesis Pharmaceuticals Inc sector.
Above is snippet of Google Trends for "Sunesis Pharmaceuticals Inc" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Sunesis, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
